Law360, New York (March 04, 2008, 12:00 AM ET) -- Chief Justice John Roberts' recusal from participating in a recent U.S. Supreme Court decision, preventing what would have been a decisive vote in a product liability suit against Pfizer Inc., has renewed concerns about the high court's recusal process.
As a result of the 4-4 split by the remaining justices overhearing the case, the Supreme Court affirmed a lower court's ruling allowing Michigan residents to advance claims against Pfizer unit Warner-Lambert over the diabetes drug Rezulin. An evenly split court automatically upholds a lower court's ruling...
High Court Recusals Questioned After Split Rulings
To view the full article, take a free trial now.
